Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

VasQ External Support for Arteriovenous Fistula

NCT: NCT03242343 · COMPLETED

NCT IDNCT03242343
StatusCOMPLETED
Start Date2017-11-29
Completion2022-04-03

Brief Summary

This is a prospective clinical study of the VasQ external support for arteriovenous fistulas. The device is designed to improve fistula outcomes by optimizing the geometrical configuration of the fistula, influencing hemodynamics, minimizing turbulence and promote laminar flow. All patients will be implanted with the VasQ device and will be followed up for a duration of 24 months.

Frequently Asked Questions

What is VasQ External Support for Arteriovenous Fistula?

VasQ External Support for Arteriovenous Fistula is a clinical trial registered under NCT03242343. Current status: COMPLETED.

What is the status of NCT03242343?

The current status of NCT03242343 (VasQ External Support for Arteriovenous Fistula) is: COMPLETED.

When did VasQ External Support for Arteriovenous Fistula start?

VasQ External Support for Arteriovenous Fistula started on 2017-11-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.